Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis

Wen Hong Shen1, Jianli Wang, Jingjing Wu

  • 1Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Cancer Research
|June 17, 2006
PubMed

Insights

The tumor suppressor p53 (also known as TP53) targets the MKP2 gene to induce apoptosis. This discovery reveals a new p53 binding site and highlights MKP2

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • The p53 tumor suppressor is crucial for cellular responses like apoptosis and cell cycle arrest, acting through transcriptional control of target genes.
  • Understanding novel p53 target genes is essential for elucidating its diverse regulatory functions in cellular processes.

Purpose of the Study:

  • To identify and characterize new p53 target genes involved in apoptosis.
  • To investigate the role of mitogen-activated protein kinase phosphatase 2 (MKP2) as a novel p53 target gene in apoptosis signaling.

Main Methods:

  • Identification of MKP2 as a transcription target of p53.
  • Characterization of a novel p53 binding site within the MKP2 promoter.
  • Analysis of MKP2 induction in response to oxidative stress and its dependence on p53.

Main Results:

  • Mitogen-activated protein kinase phosphatase 2 (MKP2) is identified as a novel transcription target of p53, specifically mediating apoptosis.
  • A unique 10-bp GC-rich palindrome (CTGGCGCCAG) in the MKP2 promoter serves as a novel p53 binding site, distinct from the consensus sequence.
  • MKP2 induction by oxidative stress is p53-dependent and prominent in apoptosis, but not cell cycle arrest; ectopic MKP2 enhances apoptosis independently of p53.

Conclusions:

  • p53 utilizes distinct binding mechanisms to regulate different target genes.
  • MKP2 is an essential p53 target gene for signaling apoptosis.
  • MKP2 plays a significant role in promoting apoptotic responses, highlighting its importance in cancer research and therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...